Topiramate add‐on therapy for drug‐resistant focal epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topiramate Add‐on Therapy for Drug‐resistant Focal Epilepsy." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438172/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients_New. Accessed 19 April 2024.
Topiramate add‐on therapy for drug‐resistant focal epilepsy. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438172/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients_New. Accessed April 19, 2024.
Topiramate add‐on therapy for drug‐resistant focal epilepsy. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438172/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients_New
Topiramate Add‐on Therapy for Drug‐resistant Focal Epilepsy [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438172/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topiramate add‐on therapy for drug‐resistant focal epilepsy
ID - 438172
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438172/all/Valacyclovir_versus_acyclovir_for_the_treatment_of_herpes_zoster_ophthalmicus_in_immunocompetent_patients_New
DB - Evidence Central
DP - Unbound Medicine
ER -